Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akari Therapeutics PLC

1.40
-0.0400-2.78%
Post-market: 1.400.00000.00%16:05 EDT
Volume:2.48K
Turnover:3.48K
Market Cap:40.43M
PE:-0.57
High:1.43
Open:1.43
Low:1.38
Close:1.44
Loading ...
Aug 20, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 20, 2024

Major Issues Report

Form 8-K - Current report
Jul 02, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 19, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Jun 07, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Jun 05, 2024

Major Issues Report

Form 8-K - Current report
Jun 04, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 04, 2024

Major Issues Report

Form 8-K - Current report
May 16, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2024

Major Issues Report

Form 8-K - Current report
May 01, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 01, 2024

Major Issues Report

Form 8-K - Current report
Apr 11, 2024

Major Issues Report

Form 8-K - Current report
Apr 01, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Mar 11, 2024

Major Issues Report

Form 8-K - Current report
Mar 05, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations